Lively Biotech has obtained optimistic suggestions from regulators on a protocol modification to its ongoing proof-of-concept scientific trial evaluating tasquinimod in sufferers with myelofibrosis, a...
The U.S. Meals and Drug Administration (FDA) has accepted PD-L1 IHC 22C3 pharmDx, Code SK006, as a companion diagnostic to assist establish sufferers with epithelial...
ByABC7 Chicago Digital Workforce Sunday, June 30, 2024 1:15AMA 3-year-old Chicago boy, Louis Gottschalk, who's battling leukemia helped raised cash for pediatric...